Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1981 3
1986 1
1987 1
1989 1
1992 1
1993 4
1994 1
1996 3
1997 2
1999 5
2000 2
2001 2
2002 1
2003 4
2005 3
2006 3
2007 5
2008 10
2009 8
2010 7
2011 6
2012 8
2013 18
2014 10
2015 3
2016 11
2017 16
2018 5
2019 8
2020 17
2021 23
2022 20
2023 21
2024 7

Text availability

Article attribute

Article type

Publication date

Search Results

217 results

Results by year

Filters applied: . Clear all
Page 1
Two Randomized Phase 3 Studies of Aducanumab in Early Alzheimer's Disease.
Budd Haeberlein S, Aisen PS, Barkhof F, Chalkias S, Chen T, Cohen S, Dent G, Hansson O, Harrison K, von Hehn C, Iwatsubo T, Mallinckrodt C, Mummery CJ, Muralidharan KK, Nestorov I, Nisenbaum L, Rajagovindan R, Skordos L, Tian Y, van Dyck CH, Vellas B, Wu S, Zhu Y, Sandrock A. Budd Haeberlein S, et al. Among authors: muralidharan kk. J Prev Alzheimers Dis. 2022;9(2):197-210. doi: 10.14283/jpad.2022.30. J Prev Alzheimers Dis. 2022. PMID: 35542991 Clinical Trial.
Extracellular Vesicles in Glioblastoma Tumor Microenvironment.
Yekula A, Yekula A, Muralidharan K, Kang K, Carter BS, Balaj L. Yekula A, et al. Among authors: muralidharan k. Front Immunol. 2020 Jan 21;10:3137. doi: 10.3389/fimmu.2019.03137. eCollection 2019. Front Immunol. 2020. PMID: 32038644 Free PMC article. Review.
Investigating Partially Discordant Results in Phase 3 Studies of Aducanumab.
Mallinckrodt C, Tian Y, Aisen PS, Barkhof F, Cohen S, Dent G, Hansson O, Harrison K, Iwatsubo T, Mummery CJ, Muralidharan KK, Nestorov I, Nisenbaum L, Rajagovindan R, von Hehn C, van Dyck CH, Vellas B, Wu S, Zhu Y, Sandrock A, Chen T, Budd Haeberlein S. Mallinckrodt C, et al. Among authors: muralidharan kk. J Prev Alzheimers Dis. 2023;10(2):171-177. doi: 10.14283/jpad.2023.6. J Prev Alzheimers Dis. 2023. PMID: 36946443 Clinical Trial.
AMAN with Ophthalmoparesis: A Rare Presentation.
Budumuru U, Muralidharan K, Sowmini PR, Velayutham SS, Jeyaraj KM, Saravanan RV, Krishnan M. Budumuru U, et al. Among authors: muralidharan k. J Assoc Physicians India. 2023 Nov;71(11):103-104. doi: 10.59556/japi.71.0385. J Assoc Physicians India. 2023. PMID: 38720508
Revisiting the "String of Pearls" Sign.
Nivalika A, Muralidharan K, Rao R. Nivalika A, et al. Among authors: muralidharan k. Indian Dermatol Online J. 2023 Jun 28;14(4):567-568. doi: 10.4103/idoj.idoj_523_22. eCollection 2023 Jul-Aug. Indian Dermatol Online J. 2023. PMID: 37521214 Free PMC article. No abstract available.
Germinal center responses to SARS-CoV-2 mRNA vaccines in healthy and immunocompromised individuals.
Lederer K, Bettini E, Parvathaneni K, Painter MM, Agarwal D, Lundgreen KA, Weirick M, Muralidharan K, Castaño D, Goel RR, Xu X, Drapeau EM, Gouma S, Ort JT, Awofolaju M, Greenplate AR, Le Coz C, Romberg N, Trofe-Clark J, Malat G, Jones L, Rosen M, Weiskopf D, Sette A, Besharatian B, Kaminiski M, Hensley SE, Bates P, Wherry EJ, Naji A, Bhoj V, Locci M. Lederer K, et al. Among authors: muralidharan k. Cell. 2022 Mar 17;185(6):1008-1024.e15. doi: 10.1016/j.cell.2022.01.027. Epub 2022 Feb 2. Cell. 2022. PMID: 35202565 Free PMC article.
217 results